1,199
Views
30
CrossRef citations to date
0
Altmetric
Laboratory Study

Protective Effect of Melatonin and 1,25-Dihydroxyvitamin D3 on Renal Ischemia–Reperfusion Injury in Rats

, , , &
Pages 374-379 | Received 02 Sep 2012, Accepted 09 Dec 2012, Published online: 29 Jan 2013

Figures & data

Figure 1.  Creatinine levels. Results are expressed as a mean ± SEM.Note: *C versus IR and C versus VD3 p = 0.004; #IR versus VD3, p = 0.009; IR versus M and IR versus M + VD3, p = 0.004. C: control, I/R: ischemia–reperfusion, VD3: 1,25-dihydroxyvitamin D3, M: melatonin, M + VD3: melatonin + 1,25-dihydroxyvitamin D3.

Figure 1.  Creatinine levels. Results are expressed as a mean ± SEM.Note: *C versus IR and C versus VD3 p = 0.004; #IR versus VD3, p = 0.009; IR versus M and IR versus M + VD3, p = 0.004. C: control, I/R: ischemia–reperfusion, VD3: 1,25-dihydroxyvitamin D3, M: melatonin, M + VD3: melatonin + 1,25-dihydroxyvitamin D3.

Figure 2.  Blood urea nitrogen (BUN) levels.Note: *C versus IR and C versus VD3, p = 0.004; #IR versus VD3, IR versus M and IR versus M + VD3, p = 0.002. For abbreviations, see legend to Figure 1.

Figure 2.  Blood urea nitrogen (BUN) levels.Note: *C versus IR and C versus VD3, p = 0.004; #IR versus VD3, IR versus M and IR versus M + VD3, p = 0.002. For abbreviations, see legend to Figure 1.

Figure 3.  Renal tissue glutathione (GSH) levels.Note: *C versus IR and p = 0.015; #IR versus VD3 and IR versus M, p = 0.009. For abbreviations, see legend to Figure 1.

Figure 3.  Renal tissue glutathione (GSH) levels.Note: *C versus IR and p = 0.015; #IR versus VD3 and IR versus M, p = 0.009. For abbreviations, see legend to Figure 1.

Figure 4.  Renal tissue superoxide dismutase (SOD) activities.Note: *C versus IR, p = 0.016; #IR versus VD3 and IR versus M, p = 0.004; IR versus M + VD3, p = 0.03. For abbreviations, see legend to Figure 1.

Figure 4.  Renal tissue superoxide dismutase (SOD) activities.Note: *C versus IR, p = 0.016; #IR versus VD3 and IR versus M, p = 0.004; IR versus M + VD3, p = 0.03. For abbreviations, see legend to Figure 1.

Figure 5.  Renal tissue malondialdehyde (MDA) levels.Note: *C versus VD3, p = 0.002; C versus M and C versus M + VD3, p = 0.004; #IR versus VD3, p = 0.009; IR versus M and IR versus M +VD3, p = 0.015. For abbreviations, see legend to Figure 1.

Figure 5.  Renal tissue malondialdehyde (MDA) levels.Note: *C versus VD3, p = 0.002; C versus M and C versus M + VD3, p = 0.004; #IR versus VD3, p = 0.009; IR versus M and IR versus M +VD3, p = 0.015. For abbreviations, see legend to Figure 1.

Figure 6.  Renal tissue nitrite + nitrate (NOx) levels.Note: *C versus IR, p = 0.015; #IR versus VD3, IR versus M and IR versus M + VD3, p = 0.002. For abbreviations, see legend to Figure 1.

Figure 6.  Renal tissue nitrite + nitrate (NOx) levels.Note: *C versus IR, p = 0.015; #IR versus VD3, IR versus M and IR versus M + VD3, p = 0.002. For abbreviations, see legend to Figure 1.

Figure 7.  PAS staining of kidney sections of control (A), I/R (B), Mel + I/R (C), VD3+ I/R (D), and Mel + VD3+ I/R (E) groups. In the I/R group, extensive necrosis plus dilation, flattening of epithelium, and loss of brush border in proximal tubuli (arrow) were seen (Glomeruli; asterisk) (bar = 20 μm).

Figure 7.  PAS staining of kidney sections of control (A), I/R (B), Mel + I/R (C), VD3+ I/R (D), and Mel + VD3+ I/R (E) groups. In the I/R group, extensive necrosis plus dilation, flattening of epithelium, and loss of brush border in proximal tubuli (arrow) were seen (Glomeruli; asterisk) (bar = 20 μm).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.